ArticleEndocrine-related cancer2021
Development of improved SRC-3 inhibitors as breast cancer therapeutic agents.
Li Qin et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
13 papers cite it
this papercites it
ArticleEndocrine-related cancer2021
Li Qin et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.